Health and Healthcare
Meet the Newest Company to Make the Coronavirus Stock List
Published:
More investors now consider BioHiTech Global Inc. (NASDAQ: BHTG) to be among those on the growing list of COVID-19 stocks. Its shares more than doubled to start out the week, despite a lack of major news about the company.
Earlier this month, the stock saw over a 50% move when news that it is now focusing its efforts on the coronavirus originally came out. BioHiTech is a waste removal and cleaning company that provides technological, biological and mechanical engineering solutions for the control, reduction or reuse of organic and municipal waste worldwide.
BioHiTech has collaborated with Altapure to offer its AP-4 disinfectant, which is capable of killing any virus, both in the air and on surfaces, via its vapor and aerosol system. Obviously there has been increased demand for aerosol disinfectants as coronavirus cases have climbed, and BioHiTech appears to be positioned very well to fill this demand.
The Altapure AP-4 is an enhanced, automated and touchless high-level disinfection sub-micron aerosol system launched in 2017, providing a safe process and rapid kill of spores, viruses and vegetative bacteria.
Customers could use this system to target such areas as infirmaries, guest or patient rooms, classrooms and small common areas. Anything from small businesses and hospitals to larger corporations would have a use for this.
BioHiTech stock traded up about 120% to $3.34 on Monday, in a 52-week range of $1.01 to $4.40. The consensus price target is $3.50.
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.